Public Profile

Alfasigma USA Inc.

Alfasigma USA Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America. Founded in 2015, the company has quickly established itself as a leader in the development and distribution of innovative healthcare solutions. Specialising in prescription pharmaceuticals, Alfasigma focuses on therapeutic areas such as gastroenterology, central nervous system disorders, and women's health. Their core products are distinguished by their commitment to quality and efficacy, addressing unmet medical needs with a patient-centric approach. With a strong market position, Alfasigma USA Inc. has achieved notable milestones, including strategic partnerships and a growing portfolio of proprietary medications. The company continues to enhance its reputation as a trusted provider of advanced therapeutic options in the competitive pharmaceutical landscape.

DitchCarbon Score

How does Alfasigma USA Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Alfasigma USA Inc.'s score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

Alfasigma USA Inc.'s reported carbon emissions

Alfasigma USA Inc. currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or initiatives documented. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the absence of data may indicate a need for enhanced transparency in their environmental practices. As the industry increasingly prioritises climate action, it is essential for companies like Alfasigma USA Inc. to establish clear emissions reduction goals and report on their progress to align with global sustainability standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Alfasigma USA Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Alfasigma USA Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Alfasigma USA Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Ra Chem Pharma

IN
Health Services
Updated 10 days ago

Claymon Laboratories Ltd.

IE
Health Services
Updated 3 days ago

I-MED

AU
Health Services
Updated 10 days ago

Caris Life Sciences

US
Health Services
Updated 10 days ago

Phonak Canada Limited

CA
Health Services
Updated 3 days ago

ComCare Medical B.V.

NL
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers